Financial Statements Notes to the Group Accounts 1.
Segmental analysis The Groups sales, marketing and research activities are organised into four global market sectors, being Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals.
These are the segments for which summary management information ispresented to the Groups Executive Committee, which is deemed to be the Groups Chief Operating Decision Maker.
A review ofeachsector can be found within the Strategic Report on pages 14 to 20.
There is no material trade between segments.
Segmental results include items directly attributable to a specific segment as well asthose that can be allocated on a reasonable basis.
Segment assets consist primarily of property, plant and equipment, intangible assets, inventories and trade and other receivables.
2017 2016 m m Restated Income statement Revenue Personal Care 466.6 420.6 Life Sciences 322.6 292.2 2 Performance Technologies 456.9 405.6 2 Industrial Chemicals 127.0 125.2 Total Group revenue 1,373.1 1,243.6 Adjusted operating profit Personal Care 155.5 143.1 Life Sciences 97.0 82.0 2 Performance Technologies 75.4 66.6 2 Industrial Chemicals 4.3 6.5 Total Group operating profit before exceptional items, acquisition costs and amortisation of intangible assets arisingonacquisition 332.2 298.2 1 Exceptional items, acquisition costs and amortisation of intangible assets arising on acquisition 6.2 12.6 Total Group operating profit 326.0 285.6 1 Relates to Personal Care 0.6m 2016: 0.8m, Life Sciences 3.2m 2016: 11.3m, Performance Technologies 0.6m 2016: 0.5m, Industrial Chemicals 0.1m 2016: nil and operations discontinued in prior years 1.7m 2016: nil 2 2016 sector revenue and adjusted operating profit have been increased by a net of 3.1m and 0.4m respectively in Performance Technologies for product portfolio changes, with corresponding reductions in Industrial Chemicals.
Balance sheet Total assets Segment total assets: Personal Care 561.4 527.3 Life Sciences 358.9 315.0 Performance Technologies 444.0 389.4 Industrial Chemicals 166.7 149.8 Total segment assets 1,531.0 1,381.5 Tax assets 33.1 56.3 Retirement benefit assets 19.1 Cash and investments 65.5 62.0 Total Group assets 1,648.7 1,499.8 Capital expenditure and depreciation 2017 2016 m m Additions to Additions to non-current Depreciation and non-current Depreciation and assets amortisation assets amortisation Personal Care 50.5 14.0 31.4 13.0 Life Sciences 41.6 14.8 21.2 13.6 Performance Technologies 56.3 18.5 43.8 16.8 Industrial Chemicals 15.9 6.0 12.0 5.8 Total Group 164.3 53.3 108.4 49.2 Croda International Plc 100 Annual Report and Accounts 2017
